口腔医学 ›› 2025, Vol. 45 ›› Issue (5): 371-375.doi: 10.13591/j.cnki.kqyx.2025.05.009

• 基础与临床研究 • 上一篇    下一篇

塞来昔布超前镇痛对下颌后牙牙髓炎治疗术中和术后疼痛的影响

王广鸣1,2,3,4, 张光东1,2,3()   

  1. 1 南京医科大学附属口腔医院综合诊疗科,江苏南京(210029)
    2 口腔疾病研究及防治国家级重点实验室培育点,江苏南京(210029)
    3 江苏省口腔转化医学工程研究中心,江苏南京(210029)
    4 联勤保障部队第九〇四医院口腔科,江苏无锡(214000)
  • 收稿日期:2024-10-22 出版日期:2025-05-28 发布日期:2025-05-21
  • 通讯作者: 张光东 E-mail:egd_zhang@njmu.edu.cn
  • 基金资助:
    南京市卫生科技发展专项资金项目计划(YKK24293)

Effect of celecoxib preemptive analgesia on pain during and after treatment of mandibular posterior pulpitis

WANG Guangming1,2,3,4, ZHANG Guangdong1,2,3()   

  1. Department of General Dentistry, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing 210029, China
  • Received:2024-10-22 Online:2025-05-28 Published:2025-05-21

摘要:

目的 评价塞来昔布超前镇痛对下颌后牙牙髓炎行根管治疗过程中疼痛的影响及其安全性。方法 120例下颌后牙不可复性牙髓炎行根管治疗的患者,随机分为A组为对照组,B组为布洛芬组,C组为塞来昔布组。术前0.5 h分别给予安慰剂、300 mg布洛芬和200 mg塞来昔布的标准口服剂量。术中采用2%利多卡因行下牙槽神经阻滞麻醉,完成开髓、拔髓、根管预备、根管内氢氧化钙消毒及封药。患者对治疗术前、术中及术后的疼痛程度采用数字评定量表(NRS)0-10版进行评价,并记录麻醉起效、持续时间和不良反应。结果 所有病例均有不同程度疼痛;但是塞来昔布组术中和术后NRS评分低于布洛芬组和对照组(P<0.05);布洛芬组术中NRS评分和对照组没有统计学差异(P>0.05),而术后评分低于对照组(P<0.05);三组麻醉持续时间无统计学差异(P>0.05),塞来昔布组麻醉起效时间短于布洛芬组和对照组(P<0.05);布洛芬组麻醉起效时间短于对照组(P<0.05);三组麻醉不良反应发生率比较差异无统计学意义(P>0.05)。结论 超前口服塞来昔布用于下颌后牙不可复性牙髓炎患者的根管治疗中,能有效提高下牙槽神经阻滞麻醉的效果,缩短麻醉起效时间,减轻患者术中和术后的疼痛,未增加不良反应发生率,值得推广应用。

关键词: 塞来昔布, 超前镇痛, 不可复性牙髓炎, 下牙槽神经阻滞麻醉, 根管治疗

Abstract:

Objective To evaluate the effect and safety of celecoxib preemptive analgesia on pain during root canal treatment of mandibular posterior pulpitis. Methods Patients(n=120) with irreversible pulpitis of mandibular posterior teeth who underwent root canal treatment were randomly divided into group A as control group, group B as ibuprofen group and group C as celecoxib group. Standard oral doses of placebo, 300 mg ibuprofen, and 200 mg celecoxib were respectively given 0.5 hours before surgery. During the operation, 2% lidocaine was used for inferior alveolar nerve block anesthesia. Pulp opening, pulp extraction, root canal preparation, root canal calcium hydroxide disinfection and drug sealing were completed. The degree of pain before, during, and after treatment was evaluated using digital rating scale (NRS) 0-10, and the onset, duration, and adverse effects of anesthesia were recorded. Results All cases had different degree of pain. However, the NRS score in celeoxib group was lower than that in ibuprofen group and control group (P<0.05). There was no significant difference in NRS score between ibuprofen group and control group (P>0.05), but postoperative score of ibuprofen group was lower than control group (P<0.05). There was no significant difference in the duration of anesthesia among the three groups (P>0.05). The onset time of anesthesia in celecoxib group was shorter than that in ibuprofen group and control group (P<0.05). The onset time of anesthesia in ibuprofen group was shorter than that in control group (P<0.05). There was no significant difference in the incidence of anesthesia adverse reactions among the three groups (P>0.05). Conclusion In the root canal treatment of mandibular posterior tooth irreversible pulpitis, oral celecoxib can effectively improve the effect of inferior alveolar nerve block anesthesia, shorten the onset time of anesthesia, reduce the intraoperative and postoperative pain of patients, and do not increase the incidence of adverse reactions, which is worthy of promotion and application.

Key words: celecoxib, preemptive analgesia, irreversible pulpitis, inferior alveolar nerve block anesthesia, root canal therapy

中图分类号: